携带致病性DMD基因变异的女性肌肉参与:一项为期6.5年的随访研究
Zhe Lyu1, Nanna Scharff Poulsen1, Heini Joensen1
1Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Journal of neuromuscular diseases
|January 9, 2026
概括
患有致病性DMD基因变异的妇女的肌肉脂肪进展缓慢. 然而,严重的基线MRI异常表明进展更快,有助于预测疾病轨迹.
科学领域:
- 遗传学和肌肉 Dystrophy 研究研究.
- 在遗传疾病中的生物标志物分析.
- 在神经肌肉疾病中的医学成像.
背景情况:
- 患有致病性DMD基因变异的女性可能会经历肌肉衰弱和脂肪替代.
- 这些女性肌肉参与的长期自然史尚未得到充分理解.
研究的目的:
- 研究患有致病性DMD基因变异的女性肌肉功能和脂肪分量的6.5年变化.
- 增强对这一群体疾病进展和自然史的理解.
主要方法:
- 对34名患有致病性DMD基因变异 (Duchenne和Becker类型) 的女性进行了长度研究.
- 使用迪克森MRI评估肌肉脂肪分数,通过异动力学动力学评估肌肉强度,以及生物标志物 (肌酸激酶,肌球蛋白).
- 在基线和6.5年后进行的评估.
主要成果:
- 在6.5年内,在腰部,大腿和小腿观察到肌肉脂肪分数的显著增加.
- 虽然平均增加很小 (<2%),但一些患有严重基线异常的个体显示脂肪分数大幅增加 (高达31%).
- 在DMD携带者和BMD携带者之间整体进展没有显著差异,但仅在DMD携带者中才出现快速进展. 强度和生物标志物的轻微变化被注意到.
结论:
- 在患有致病性DMD基因变异的女性中,肌肉参与的进展通常缓慢.
- 严重的基线MRI异常预测更快的肌肉脂肪分数进展.
- 基线MRI发现可能有助于预测该队列的未来疾病进展.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
393
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
393


